Cargando…
Novel Prognostic Factors Associated with Cell Cycle Control in Sporadic Medullary Thyroid Cancer Patients
BACKGROUND: Medullary thyroid cancer (MTC) is a rare neuroendocrine-derived malignancy. It is represented by sporadic and familiar forms, and both can have RET oncogene mutations. Numerous markers can be used to define MTC; however, none is generally approved for predicting the outcome of sporadic M...
Autores principales: | Pezzani, Raffaele, Bertazza, Loris, Cavedon, Elisabetta, Censi, Simona, Manso, Jacopo, Watutantrige-Fernando, Sara, Pennelli, Gianmaria, Galuppini, Francesca, Barollo, Susi, Mian, Caterina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398011/ https://www.ncbi.nlm.nih.gov/pubmed/30911297 http://dx.doi.org/10.1155/2019/9421079 |
Ejemplares similares
-
Prognostic Impact of miR-224 and RAS Mutations in Medullary Thyroid Carcinoma
por: Cavedon, Elisabetta, et al.
Publicado: (2017) -
Serum miR-375 for Diagnostic and Prognostic Purposes in Medullary Thyroid Carcinoma
por: Censi, Simona, et al.
Publicado: (2021) -
Overexpression of L-Type Amino Acid Transporter 1 (LAT1) and 2 (LAT2): Novel Markers of Neuroendocrine Tumors
por: Barollo, Susi, et al.
Publicado: (2016) -
Differentiated Thyroid Carcinoma in Pediatric Age: Genetic and Clinical Scenario
por: Galuppini, Francesca, et al.
Publicado: (2019) -
The role of the size in thyroid cancer risk stratification
por: Vianello, Federica, et al.
Publicado: (2021)